This product is suitable for the maintenance treatment of asthma in adults and adolescents aged 12 years and above. Including: 1. Patients who are not adequately controlled by inhaled corticosteroids; 2. Patients who are not adequately controlled by long-acting β2 receptor agonists and low-dose inhaled corticosteroids
Let us work together to protect precious health